scispace - formally typeset
F

F. Ivy Carroll

Researcher at Research Triangle Park

Publications -  301
Citations -  11139

F. Ivy Carroll is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Nicotinic agonist & Dopamine transporter. The author has an hindex of 52, co-authored 301 publications receiving 10411 citations. Previous affiliations of F. Ivy Carroll include RTI International & St. Joseph's Hospital and Medical Center.

Papers
More filters
Journal ArticleDOI

Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 3′-(Substituted Phenyl)epibatidine Analogues. Nicotinic Partial Agonists

TL;DR: This paper reported the synthesis, receptor binding, and in vivo pharmacological properties of a series of 3'-(substituted phenyl)epibatidine analogues (5a-m).
Journal ArticleDOI

Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.

TL;DR: It is suggested that the region from the N terminal to the start of the TMH3 of the μ opioid receptor determines the binding affinity of RTI‐4614‐4 and its isomers and that the e3 loop also plays a major role in determining thebinding affinity of μ agonist peptides.
Journal ArticleDOI

Distinct Molecular Recognition of Psychostimulants by Human and Drosophila Serotonin Transporters

TL;DR: Models for the 3-phenyltropane analogs indicate that a region exists around the aromatic ring where decreased electron density is favored, particularly for hSERT, which may indicate pi-pi stacking with an aromatic amino acid residue in SERT.
Journal ArticleDOI

Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.

TL;DR: Results suggest that α4 β2 receptors are sufficient to mediate abuse-related rate-increasing effects of nAChR agonists in this ICSS procedure, and nicotine effects at non-α4β2 nA ChRs appear to oppose and limit abuse- related effects mediated by α4β 2 receptors, although tolerance can develop to these non-β2 effects.